Assessing Self-Injection Experience in Rheumatoid Arthritis Patients
Author Information
Author(s): Dorothy Keininger, Geoffroy Coteur
Primary Institution: UCB Pharma SA
Hypothesis
The study aimed to develop a questionnaire to measure overall patient experience with subcutaneous self-injection and investigate its psychometric properties.
Conclusion
The Self-Injection Assessment Questionnaire (SIAQ) was shown to be a valid and reliable tool for evaluating self-injection experiences in patients with rheumatoid arthritis.
Supporting Evidence
- The SIAQ demonstrated internal consistency and reproducibility with Cronbach's α > 0.70.
- Patients with lower self-confidence and higher anxiety before self-injection reported lower satisfaction.
- Exploratory factor analysis confirmed the relationships between items and domains in the SIAQ.
Takeaway
This study created a questionnaire to help patients with rheumatoid arthritis feel better about giving themselves injections, and it works well.
Methodology
The SIAQ was tested for validity and reliability in patients with rheumatoid arthritis who self-injected certolizumab pegol during a clinical trial.
Potential Biases
Participants may not have been representative of all rheumatoid arthritis patients, as those with severe anxiety or dexterity issues may have opted out.
Limitations
The study had a small sample size and potential selection bias, as participants were volunteers who were deemed capable of self-injection.
Participant Demographics
The mean age of participants was 51.8 years, with 76.3% female and 99% Caucasian.
Statistical Information
P-Value
0.009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website